Madison Dearborn Partners to Acquire Significant Ownership Stake in NextGen Healthcare, Partnering with Thoma Bravo to Drive Continued Growth and Innovation Chicago-based private equity firm Madison Dearborn Partners, LLC (MDP) has entered into a definitive agreement with Thoma Bravo to…
Encompass Health Opens Call for 2025 Research Grant Applications to Advance Inpatient Rehabilitation Science Encompass Health, one of the nation’s leading providers of inpatient rehabilitation services, has officially launched its request for research grant applications for the 2025 cycle. The…
Arizona Complete Health Joins Settlement Agreement to Advance Statewide ALTCS Medicaid Contract Centene Corporation (NYSE: CNC), a Fortune 50 healthcare enterprise dedicated to transforming the health of the communities it serves, announced that its Arizona subsidiary, Arizona Complete Health, has…
The Cigna Group Reports Strong First Quarter 2025 Results and Raises Full-Year Outlook Amid Continued Growth Across Core Platforms Global health company The Cigna Group (NYSE: CI) announced robust financial results for the first quarter of 2025, underpinned by disciplined…
Viridian Therapeutics Announces Inducement Equity Grants for New Hires in Accordance with Nasdaq Rule 5635(c)(4) Viridian Therapeutics, Inc. (Nasdaq: VRDN), a clinical-stage biopharmaceutical company dedicated to advancing innovative therapies for patients with serious and rare diseases, today announced the approval…
University of Phoenix and NCH Healthcare Partner to Deliver Education and Tuition Benefits for Workforce Development In a strategic move to enhance workforce development and support the professional growth of healthcare professionals, the University of Phoenix has announced a new…
AI-Driven HSS Study Honored for Uncovering Risk Factors Behind Severe Postoperative Pain After Knee Replacement A groundbreaking study by researchers at Hospital for Special Surgery (HSS) that harnesses artificial intelligence (AI) to identify patients at risk of experiencing severe pain…
AN2 Therapeutics Reports Phase 3 Data from EBO-301 Trial and Details Strategic Pipeline Advancements Across Boron Chemistry Platform AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company pioneering boron-based small molecule therapeutics, has announced topline results from the truncated Phase…
Exact Sciences Reports First-Quarter 2025 Financial Results, Launches Two New Cancer Detection Tests Exact Sciences Corp. (Nasdaq: EXAS), a global leader in cancer diagnostics and early detection, announced its financial results for the first quarter ended March 31, 2025. The…
Bio-Rad Laboratories Reports First-Quarter 2025 Financial Results Amid Market Challenges and Shifting Demand Dynamics Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics, today announced its financial results for the first quarter…
Sensus Healthcare Champions Skin Cancer Awareness Month with Focus on Education, Prevention, and Non-Invasive Treatment Innovations May marks Skin Cancer Awareness Month, and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company pioneering non-invasive and minimally invasive treatments for oncological…
Team-Based Caregiver Training Linked to Improved Autism Outcomes, ACES Study Finds Children with autism spectrum disorder (ASD) experience significantly better developmental outcomes when their caregivers participate in structured, team-based training programs, according to a new report from ACES 2020, LLC…